Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models

Abstract

The fine management of both peripheral and central inflammation may offer a promising therapeutic approach to prevent or slow down some behavioural aspects in α-synucleinopathies.